BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,000 | -86.2% | 116 | -87.0% | 0.00% | -100.0% |
| Q2 2022 | $130,000 | -99.7% | 892 | -99.8% | 0.00% | -99.8% |
| Q1 2022 | $48,170,000 | -8.1% | 406,256 | +6.8% | 0.43% | -2.1% |
| Q4 2021 | $52,428,000 | +385.4% | 380,437 | +389.3% | 0.44% | +356.2% |
| Q3 2021 | $10,801,000 | +7.6% | 77,758 | -24.8% | 0.10% | +10.3% |
| Q2 2021 | $10,035,000 | +38.9% | 103,364 | -2.2% | 0.09% | +29.9% |
| Q1 2021 | $7,225,000 | -16.6% | 105,712 | +4.5% | 0.07% | -26.4% |
| Q4 2020 | $8,666,000 | +11.7% | 101,112 | -15.3% | 0.09% | -10.8% |
| Q3 2020 | $7,758,000 | +10.5% | 119,340 | +24.3% | 0.10% | +3.0% |
| Q2 2020 | $7,022,000 | +56.3% | 96,041 | -27.3% | 0.10% | +25.3% |
| Q1 2020 | $4,493,000 | -41.1% | 132,037 | -5.7% | 0.08% | -22.5% |
| Q4 2019 | $7,624,000 | +24.8% | 140,046 | -4.3% | 0.10% | +18.6% |
| Q3 2019 | $6,107,000 | +34.8% | 146,376 | +41.5% | 0.09% | +24.6% |
| Q2 2019 | $4,531,000 | -15.9% | 103,480 | -1.1% | 0.07% | -20.7% |
| Q1 2019 | $5,388,000 | +20.1% | 104,679 | -13.7% | 0.09% | -2.2% |
| Q4 2018 | $4,486,000 | – | 121,306 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |